News - Greater Bay Area International Clinical Trial Institute

08.07.2026

GBAICTI and Amgen Collaborate to Advance Healthcare Innovation and Improve Patient Care in Hong Kong

The Greater Bay Area International Clinical Trial Institute (“GBAICTI”) and biotechnology company Amgen today announced their collaboration through the signing of a Memorandum of Understanding to strengthen capabilities and improve patient outcomes in Hong Kong and the wider Greater Bay Area (“GBA”).

25.06.2026

GBAICTI Welcomes the Launch of the Public Consultation on “The First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)”

We welcome the launch of the public consultation on “The First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)”, a significant milestone that sets out a forward-looking vision and strategic direction for the city’s development. The Plan provides an important framework to support Hong Kong’s high-quality development and its deeper integration into the overall national development agenda.

18.06.2026

Department of Health’s introduction of a “Priority Review Pathway”

GBAICTI welcomes the Department of Health’s introduction of a “Priority Review Pathway” under the existing “1+” drug approval mechanism, and supports the Hospital Authority’s establishment of the Office for Introducing Innovative Drugs and Medical Devices (the Office).

08.06.2026

Save the Date: GBAICTI Regional Clinical Trial Conference 2026

Join us as GBAICTI convenes leaders across the clinical research ecosystem to advance collaboration and innovation.

28.05.2026

GBAICTI Welcomes Danish Health and Life Sciences Delegation

The Greater Bay Area International Clinical Trial Institute (GBAICTI) was pleased to host a delegation from the Royal Danish Consulate General in Guangzhou for a site visit to the Hetao area.

13.05.2026

Showcasing Hong Kong’s Clinical Trial Strengths at Asia Summit on Global Health 2026

The Greater Bay Area International Clinical Trial Institute (GBAICTI) participated in the Asia Summit on Global Health held from 11–12 May 2026, joining global healthcare leaders and industry stakeholders to exchange insights and explore opportunities for collaboration in advancing innovation across the life sciences sector.